Malaque, Via Rose .

HRN: 25-95-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2024
CEFUROXIME 1.5GM (VIAL)
12/14/2024
12/15/2024
IV
1.5g
Q8hrs
Post-op Prophylaxis
Waiting Final Action 
12/14/2024
CEFUROXIME 500MG (TAB)
12/14/2024
12/20/2024
PO
1tab
BID
Post-op Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: